Advertisement
Manufacturing and Capabilities
Subscribe to Manufacturing and Capabilities

The Lead

Discovery Could Lead to Homemade Morphine, Painkillers

May 19, 2015 11:01 am | by Alicia Chang, AP Science Writer | News | Comments

Scientists have figured out all the steps to make morphine and similar painkillers without using opium poppies, potentially opening the door for home-brewed drugs. Some experts are calling for regulations to prevent tinkerers from making morphine, which can be converted into heroin.

Pharma Legacy Drives New Software, IoT Innovation

May 18, 2015 11:21 am | by Jeff Reinke, Editorial Director | Blogs | Comments

Pharmaceutical Processing sat down with Rockwell Automation’s Paula Puess and Khris...

Dyadic International Q1 Results

May 15, 2015 11:59 am | by Dyadic International | News | Comments

Dyadic International, Inc. is a global biotechnology company focused on enzymes and other...

SAFC Expands in St. Louis

May 13, 2015 11:43 am | by Sigma-Aldrich Corporation | News | Comments

Sigma-Aldrich Corporation has completed the expansion of its St. Louis facility to support...

View Sample

FREE Email Newsletter

ANI Acquires Rights to Testosterone Gel 1%

May 13, 2015 11:31 am | by ANI Pharmaceuticals | News | Comments

ANI Pharmaceuticals has acquired the approved new drug application ("NDA") for a testosterone gel 1% product previously licensed to Teva Pharmaceuticals.

Vitae Pharmaceuticals Q1 Results

May 13, 2015 11:19 am | by Vitae Pharmaceuticals | News | Comments

Vitae Pharmaceuticals, a clinical-stage biotechnology company, recently provided financial results and pipeline reports for the first quarter of 2015.

SAFC Expands Gene Therapy Facility

May 12, 2015 11:37 am | by Sigma-Aldrich Corporation | News | Comments

Sigma-Aldrich Corporation's new facility will support commercial-scale gene therapy production, testing and filling.

Advertisement

Juno Acquires Stage Cell

May 12, 2015 11:15 am | by Juno Therapeutics | News | Comments

Juno Therapeutics, a biopharmaceutical company focused on cancer treatment, announced today that it has acquired Stage Cell Therapeutics GmbH.

Inovio Unveils Clinical Trial for Ebola Immunotherapy

May 12, 2015 11:06 am | by Inovio Pharmaceuticals | News | Comments

Inovio Pharmaceuticals announced that the company has initiated a phase I trial to evaluate the safety, tolerability and immune responses of their DNA immunotherapy for Ebola.

Endo Acquires Portfolio of Branded and Generic Products

May 11, 2015 11:06 am | by Endo International | News | Comments

Endo International has acquired a broad portfolio of branded and generic injectable and established products focused on pain, anti-infectives, cardiovascular and other specialty therapeutics areas.

Global Hemophilia Therapeutics Market Surges

May 11, 2015 10:42 am | by Frost & Sullivan | News | Comments

New analysis finds that the market could reach $13.4 billion in 2019, due in part to advanced diagnosis capabilities.

Rexahn Pharmaceuticals Updates Pipeline

May 11, 2015 10:34 am | by Rexahn Pharmaceuticals | News | Comments

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing therapeutics for the treatment of cancer provided an update of its three clinical development programs.

Advertisement

BASF Sells Part of Its Pharma Business

May 11, 2015 10:20 am | by Andy Szal, Digital Reporter | News | Comments

BASF recently announced plans to sell several prominent pharmaceutical ingredients to Siegfried Holding AG for $306 million.

Bellicum Leases Space for Pilot Manufacturing Facility

May 8, 2015 11:43 am | by Bellicum Pharmaceuticals | News | Comments

Bellicum Pharmaceuticals, Inc. today announced that it has entered into a lease agreement to enable in-house cell therapy manufacturing to supply clinical trials.

3D Printing in Pharm – Packaging, Prototyping and Pills?

May 8, 2015 11:24 am | by Jeff Reinke, editorial director | Blogs | Comments

Ways to implement the manufacturing and prototyping technology within the pharmaceutical marketplace were highlighted at INTERPHEX 2015.

Novavax Announces Q1 Results

May 8, 2015 10:58 am | by Novavax | News | Comments

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced Q1 results.

Portola Pharmaceuticals Q1 Results

May 7, 2015 11:35 am | by Portola Pharmaceuticals | News | Comments

Portola Pharmaceuticals today provided a corporate update and reported its financial results for the first quarter.

Advertisement

MorphoSys Acquires Lanthio Pharma

May 7, 2015 11:16 am | by MorphoSys AG | News | Comments

MorphoSys AG announced today that it has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V.

Eli Lilly to Build Drug Delivery Innovation Center

May 6, 2015 11:20 am | by Eli Lilly | News | Comments

Eli Lilly and Company today announced plans to establish a new drug delivery and device innovation center in Cambridge, Massachusetts.

Alexion Pharma to Pay $8.4 Billion for Synageva BioPharma

May 6, 2015 11:14 am | by Tom Murphy, AP Business Writer | News | Comments

Alexion Pharmaceuticals will pay a huge premium to buy fellow rare disease treatment maker Synageva BioPharma in an $8.4-billion deal for a company with no products on the market.

Juno and Fate Therapeutics to Conduct Joint T-Cell Research

May 6, 2015 11:02 am | by Fate Therapeutics | News | Comments

Juno Therapeutics and Fate Therapeutics announced a strategic collaboration to identify and utilize small molecules to modulate Juno's genetically-engineered T cell product for potentially treating cancer patients.

Alzheimer Treatments Worth $13B by 2023

May 6, 2015 10:53 am | News | Comments

The global market for Alzheimer’s Disease treatment will more than double in value from $4.9 billion in 2013 to reach an estimated $13.3 billion by 2023.

Amyris Unveils Q1 Results

May 6, 2015 10:47 am | by Amyris | News | Comments

Amyris, Inc., the industrial bioscience company, today announced financial results for the first quarter of 2015.

Capital Investments: Regulations, Technology and ROI

May 5, 2015 10:45 am | by Jeff Reinke, Editorial director | Blogs | Comments

Pharmaceutical processors face a number of challenges in determining the direction they should take when considering internal investments – but a lack of options have never been amongst them.

Dock Management: Sealing The Perimeter

May 5, 2015 10:35 am | by Mary Blaser, Director of Marketing and Business Development, Rite-Hite Environmental Enclosures Corporation | Blogs | Comments

While it’s a vital link between a facility and the pharmaceuticals shipped in and out every day, the loading dock presents the greatest opportunity for energy losses and damage to precious materials and products.

How Shared Service Management Can Help Make Your Organization Lean

May 5, 2015 10:26 am | by Nancy Van Elsacker, President, TOPdesk | Blogs | Comments

Shared service management is an important development in the collaboration between an organization’s supporting services, and can make an organization more Lean.

BioPharma Industry Seeks Downstream Processing Advances

May 5, 2015 10:12 am | by Eric S. Langer, President, BioPlan Associates | Blogs | Comments

Downstream processing continues to impact capacity at the majority of biopharmaceutical manufacturing facilities.

Topical Treatment CMO Continues Expansion

May 5, 2015 9:55 am | by Mike Auerbach, Editor-In-Chief | Blogs | Comments

Dow Development Laboratories in California is working to position itself as the "go-to" contract manufacturer for topical product development services.

Oncobiologics Opens Manufacturing Facility in New Jersey

May 4, 2015 11:48 am | by Oncobiologics | News | Comments

The GMP commercial launch manufacturing facility in Cranbury will focus on antibody biosimilars.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading